3/23
07:20 am
phio
Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement [Yahoo! Finance]
Low
Report
Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement [Yahoo! Finance]
3/10
08:59 am
phio
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT [Yahoo! Finance]
Low
Report
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT [Yahoo! Finance]
3/10
08:35 am
phio
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT
Low
Report
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT
3/10
07:59 am
phio
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT
Medium
Report
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT
2/23
10:12 am
phio
Phio Pharmaceuticals Corp. Selected as B2i Digital Featured Company [Yahoo! Finance]
Low
Report
Phio Pharmaceuticals Corp. Selected as B2i Digital Featured Company [Yahoo! Finance]
2/10
01:00 pm
phio
Phio Pharmaceuticals (NASDAQ:PHIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
High
Report
Phio Pharmaceuticals (NASDAQ:PHIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
1/26
08:26 am
phio
Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference [Yahoo! Finance]
Medium
Report
Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference [Yahoo! Finance]